FA
ENZN

FCG Advisors’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

FCG Advisors’s Portfolio ENZN Stock Details ENZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-20,000
Closed -$21K – 94
2014
Q2 		$21K Hold
20,000
– – 0.02% 86
2014
Q1 		$21K Hold
20,000
– – 0.01% 84
2013
Q4 		$23K Buy
+20,000
New +$30.8K 0.02% 80

Other funds holding ENZN

IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

FCG Advisors's ENZN Position: Q3 2014 in Review

FCG Advisors sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q3 2014, closing a stake of 20,000 shares — an estimated $21K sold.

FCG Advisors first reported a position in ENZN in Q4 2013 and held it in 3 quarters. The position peaked at $23K in Q4 2013. 65 funds tracked by Wall St. Rank hold ENZN as of Q3 2014.

  • FCG Advisors reported no remaining ENZON PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • FCG Advisors sold 20,000 ENZON PHARMACEUTICALS INC shares in Q3 2014, an estimated $21K.
  • FCG Advisors first reported a position in ENZON PHARMACEUTICALS INC in Q4 2013 and held it in 3 quarters.
  • FCG Advisors's ENZON PHARMACEUTICALS INC position peaked at $23K in Q4 2013.
  • 65 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q3 2014.

Based on FCG Advisors's 13F filing for Q3 2014, filed 13 Nov 2014.